TY  - GEN
AU  - Kamatani,Naoyuki
AU  - Naoyuki,Kamatani
AU  - Fujimori,Shin
AU  - Shin,Fujimori
AU  - Hada,Toshikazu
AU  - Toshikazu,Hada
AU  - Hosoya,Tatsuo
AU  - Tatsuo,Hosoya
AU  - Kohri,Kenjiro
AU  - Kenjiro,Kohri
AU  - Nakamura,Toshitaka
AU  - Toshitaka,Nakamura
AU  - Ueda,Takanori
AU  - Takanori,Ueda
AU  - Yamamoto,Tetsuya
AU  - Tetsuya,Yamamoto
AU  - Yamanaka,Hisashi
AU  - Hisashi,Yamanaka
AU  - Matsuzawa,Yuji
AU  - Yuji,Matsuzawa
TI  - An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study
SN  - 1536-7355
PY  - 2011///1201
KW  - Administration, Oral
KW  - Allopurinol
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Febuxostat
KW  - Female
KW  - Follow-Up Studies
KW  - Gout
KW  - blood
KW  - Gout Suppressants
KW  - Humans
KW  - Hyperuricemia
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Thiazoles
KW  - Time Factors
KW  - Treatment Outcome
KW  - Uric Acid
KW  - Xanthine Oxidase
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/RHU.0b013e31821d352f
ER  -